213 related articles for article (PubMed ID: 31570773)
21. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
22. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
[TBL] [Abstract][Full Text] [Related]
23. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
[TBL] [Abstract][Full Text] [Related]
24. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
Yarosh W; Barrientos T; Esmailpour T; Lin L; Carpenter PM; Osann K; Anton-Culver H; Huang T
Cancer Res; 2008 Feb; 68(3):693-9. PubMed ID: 18245468
[TBL] [Abstract][Full Text] [Related]
25. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
Basu GD; Liang WS; Stephan DA; Wegener LT; Conley CR; Pockaj BA; Mukherjee P
Breast Cancer Res; 2006; 8(6):R69. PubMed ID: 17156488
[TBL] [Abstract][Full Text] [Related]
26. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.
Udabage L; Brownlee GR; Waltham M; Blick T; Walker EC; Heldin P; Nilsson SK; Thompson EW; Brown TJ
Cancer Res; 2005 Jul; 65(14):6139-50. PubMed ID: 16024615
[TBL] [Abstract][Full Text] [Related]
27. The special stemness functions of Tbx3 in stem cells and cancer development.
Dong L; Lyu X; Faleti OD; He ML
Semin Cancer Biol; 2019 Aug; 57():105-110. PubMed ID: 30268432
[TBL] [Abstract][Full Text] [Related]
28. [Expression of TBX3 mRNA and its role in the pathogenesis and metastasis of breast cancer].
Chen ZH; Lü GM; Ji TH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):87-9. PubMed ID: 19218121
[TBL] [Abstract][Full Text] [Related]
29. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.
Chakraborty G; Jain S; Kundu GC
Cancer Res; 2008 Jan; 68(1):152-61. PubMed ID: 18172307
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
32. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
33. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.
Fillmore CM; Gupta PB; Rudnick JA; Caballero S; Keller PJ; Lander ES; Kuperwasser C
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21737-42. PubMed ID: 21098263
[TBL] [Abstract][Full Text] [Related]
34. The T-Box transcription factor 3 in development and cancer.
Willmer T; Cooper A; Peres J; Omar R; Prince S
Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
[TBL] [Abstract][Full Text] [Related]
35. The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development.
Ballim RD; Mendelsohn C; Papaioannou VE; Prince S
Mol Biol Cell; 2012 Jun; 23(12):2362-72. PubMed ID: 22535523
[TBL] [Abstract][Full Text] [Related]
36. TBX3 over-expression causes mammary gland hyperplasia and increases mammary stem-like cells in an inducible transgenic mouse model.
Liu J; Esmailpour T; Shang X; Gulsen G; Liu A; Huang T
BMC Dev Biol; 2011 Oct; 11():65. PubMed ID: 22039763
[TBL] [Abstract][Full Text] [Related]
37. The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway.
Li J; Weinberg MS; Zerbini L; Prince S
Mol Biol Cell; 2013 Nov; 24(22):3569-76. PubMed ID: 24025717
[TBL] [Abstract][Full Text] [Related]
38. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.
Cui R; Takahashi F; Ohashi R; Gu T; Yoshioka M; Nishio K; Ohe Y; Tominaga S; Takagi Y; Sasaki S; Fukuchi Y; Takahashi K
Lung Cancer; 2007 Sep; 57(3):302-10. PubMed ID: 17482311
[TBL] [Abstract][Full Text] [Related]
39. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
40. YAP Overexpression in Breast Cancer Cells Promotes Angiogenesis through Activating YAP Signaling in Vascular Endothelial Cells.
Yan Y; Song Q; Yao L; Zhao L; Cai H
Anal Cell Pathol (Amst); 2022; 2022():5942379. PubMed ID: 36226237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
